47,600 Shares in Pediatrix Medical Group, Inc. $MD Acquired by Strs Ohio

Key Points

• Strs Ohio has made a new investment in Pediatrix Medical Group, acquiring 47,600 shares valued at approximately $690,000 during the first quarter.
• Other institutional investors, including Principal Financial Group and GAMMA Investing LLC, have also increased their stakes in the company, indicating strong interest from large investors.
• Pediatrix Medical Group reported earnings of $0.53 per share, exceeding analyst estimates of $0.42, with a revenue of $468.84 million for the quarter.

Strs Ohio bought a new position in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund bought 47,600 shares of the company's stock, valued at approximately $690,000. Strs Ohio owned approximately 0.06% of Pediatrix Medical Group as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in the stock. GAMMA Investing LLC grew its position in shares of Pediatrix Medical Group by 219.5% in the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after purchasing an additional 1,765 shares during the last quarter. AlphaQuest LLC raised its holdings in shares of Pediatrix Medical Group by 16.0% in the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock worth $85,000 after purchasing an additional 811 shares during the period. Squarepoint Ops LLC purchased a new stake in Pediatrix Medical Group during the fourth quarter worth approximately $132,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management purchased a new position in Pediatrix Medical Group in the first quarter valued at about $159,000. Finally, Optimize Financial Inc purchased a new position in Pediatrix Medical Group in the 1st quarter worth approximately $167,000. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Trading Up 0.4%

MD traded up $0.07 during mid-day trading on Tuesday, hitting $16.63. The stock had a trading volume of 36,451 shares, compared to its average volume of 755,372. The stock's fifty day simple moving average is $15.11 and its 200-day simple moving average is $14.24. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.80 and a quick ratio of 1.80. The firm has a market capitalization of $1.45 billion, a price-to-earnings ratio of 12.89 and a beta of 1.29. Pediatrix Medical Group, Inc. has a 1-year low of $10.40 and a 1-year high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business had revenue of $468.84 million for the quarter, compared to analysts' expectations of $464.37 million. During the same period in the previous year, the firm posted $0.34 EPS. The firm's revenue was down 7.1% compared to the same quarter last year. As a group, research analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently issued reports on MD. Zacks Research raised shares of Pediatrix Medical Group to a "strong-buy" rating in a research note on Monday, August 11th. Wall Street Zen downgraded Pediatrix Medical Group from a "strong-buy" rating to a "buy" rating in a research note on Saturday, September 13th. UBS Group upped their target price on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a research report on Thursday, August 14th. Finally, Leerink Partners upped their target price on Pediatrix Medical Group from $14.50 to $17.00 and gave the company a "market perform" rating in a research report on Friday, September 5th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $16.79.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.